Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bijan Mahboubi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Viruses|April 5, 2020
SAMHD1 Functions and Human DiseasesSi'Ana A Coggins, Bijan Mahboubi, Raymond F Schinazi, et al.
The Journal of Biological Chemistry|August 2, 2020
Mechanistic cross-talk between DNA/RNA polymerase enzyme kinetics and nucleotide substrate availability in cells: Implications for polymerase inhibitor discoverySi'Ana A Coggins, Bijan Mahboubi, Raymond F Schinazi, et al.
Pathogens & Immunity|January 19, 2019
Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage InfectionTimothy Plitnik, Mark E Sharkey, Bijan Mahboubi, et al.
Retrovirology|October 15, 2018
Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophagesBijan Mahboubi, Christina Gavegnano, Dong-Hyun Kim, et al.
Plos Pathogens|July 22, 2021
A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction siteTatsuya Maehigashi, Seohyun Ahn, Uk-Il Kim, et al.
The Journal of Biological Chemistry|January 9, 2020
The dNTPase activity of SAMHD1 is important for its suppression of innate immune responses in differentiated monocytic cellsZhihua Qin, Serena Bonifati, Corine St Gelais, et al.
Blood Cancer Journal|January 21, 2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaPatricia Johansson, Ludger Klein-Hitpass, Axel Choidas, et al.
Nature Communications|June 10, 2018
Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exitKerstin Schott, Nina V Fuchs, Rita Derua, et al.
Nature Communications|July 29, 2021
SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cellsCharlotte Martinat, Arthur Cormier, Joëlle Tobaly-Tapiero, et al.
Nature Communications|December 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repressionTejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Viruses|April 5, 2020
SAMHD1 Functions and Human DiseasesSi'Ana A Coggins, Bijan Mahboubi, Raymond F Schinazi, et al.
The Journal of Biological Chemistry|August 2, 2020
Mechanistic cross-talk between DNA/RNA polymerase enzyme kinetics and nucleotide substrate availability in cells: Implications for polymerase inhibitor discoverySi'Ana A Coggins, Bijan Mahboubi, Raymond F Schinazi, et al.
Pathogens & Immunity|January 19, 2019
Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage InfectionTimothy Plitnik, Mark E Sharkey, Bijan Mahboubi, et al.
Retrovirology|October 15, 2018
Host SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophagesBijan Mahboubi, Christina Gavegnano, Dong-Hyun Kim, et al.
Plos Pathogens|July 22, 2021
A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction siteTatsuya Maehigashi, Seohyun Ahn, Uk-Il Kim, et al.
The Journal of Biological Chemistry|January 9, 2020
The dNTPase activity of SAMHD1 is important for its suppression of innate immune responses in differentiated monocytic cellsZhihua Qin, Serena Bonifati, Corine St Gelais, et al.
Blood Cancer Journal|January 21, 2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaPatricia Johansson, Ludger Klein-Hitpass, Axel Choidas, et al.
Nature Communications|June 10, 2018
Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exitKerstin Schott, Nina V Fuchs, Rita Derua, et al.
Nature Communications|July 29, 2021
SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cellsCharlotte Martinat, Arthur Cormier, Joëlle Tobaly-Tapiero, et al.
Nature Communications|December 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repressionTejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas, et al.
Pageof 2